Search Results

Displaying Results 1-2 of 2 "'RCKT'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions

Dec 09, 2025, 11:57 ET Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions

(OTCQB: AVAI), Beam Therapeutics Inc. (NASDAQ: BEAM), CRISPR Therapeutics (NASDAQ: CRSP), Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), and Schrödinger, Inc. (NASDAQ: SDGR).

More news about: Equity Insider

Kuehn Law Encourages Investors of Rocket Pharmaceuticals, Inc. to Contact Law Firm

Sep 19, 2025, 13:30 ET Kuehn Law Encourages Investors of Rocket Pharmaceuticals, Inc. to Contact Law Firm

PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) breached their fiduciary duties to shareholders.

More news about: Kuehn Law, PLLC

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.